Ruo‐Kai Lin
Taipei Medical University(TW)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, RNA modifications and cancer, Cancer-related gene regulation, Cancer Genomics and Diagnostics, Ferroptosis and cancer prognosis
Most-Cited Works
- → Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples(2003)34 cited
- → Machine learning approaches for predicting 5‐year breast cancer survival: A multicenter study(2023)15 cited
- → Deregulation of p53 and RB Transcriptional Control Leads to Overexpression of DNA Methyltransferases in Lung Cancer(2014)11 cited
- → Polysaccharides obtained from mycelia of Cordyceps militaris attenuated doxorubicin-induced cytotoxic effects in chemotherapy(2019)10 cited
- → Abstract LB256: Circulating methylated GCM2 and TMEM240 as novel biomarkers for dynamic monitoring of breast cancer progression and treatment response(2025)
- → Additional file 1 of Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction(2020)
- hNaa10p/Human arrest-defective 1 contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing(2010)
- → Advancements in breast cancer progression monitoring: Analysis of methylated circulating cell- free DNA.(2024)
- → The Human Arrest-defective 1, A Putative Acetyltransferase, Downregulates Tumor Suppressor Gene Expression through Increasing DNA Methyltransferase 1 Activity(2009)
- → Hypermethylation of TMEM240 Involved in Expression Deficiency Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer(2021)